Heart failure management is evolving rapidly, with new insights shaping treatment strategies and patient outcomes. In this expert-led session, we delve into the latest advancements, from HFpEF diagnosis to groundbreaking findings from a decade of SGLT2 inhibition and the EMPULSE study. Gain practical knowledge on optimizing transitions in care, reducing readmissions, and improving long-term patient management. Don't miss this deep dive into cutting-edge heart failure therapy with leading national experts!

Optimizing Transition in Heart Failure Care

On the occasion of World Heart Day, this exclusive session on “Holistic Care of Heart Failure: Role of Empagliflozin” will delve into the latest advancements in heart failure management, with a special focus on HFpEF (Heart Failure with Preserved Ejection Fraction). With heart failure remaining a significant burden worldwide, this session will highlight the pivotal role of Empagliflozin in optimizing care and improving patient outcomes. Led by renowned experts Dr. HK Chopra and Dr. CK Ponde, the discussion will cover: Cutting-edge approaches to diagnosing and managing HFpEF. Insights into the evolving role of Empagliflozin as part of guideline-directed medical therapy (GDMT). Practical strategies for integrating Empagliflozin in clinical practice to maximize benefits for heart failure patients. Don’t miss this chance to deepen your expertise, gain actionable knowledge on improving heart failure outcomes, staying abreast of current treatment paradigms, and enhancing clinical practice.

Holistic care of Heart Failure: Role of empagliflozin

Discover the latest in cardiology we introduce newer drugs such as Colchicine, Ferric Carboxymaltose, Mavacamptan, and more. Explore the potential impact of these innovative medications on cardiovascular care. Stay at the forefront of cardiology advancements by joining us LIVE for this informative session. Educational Initiative supported by Mankind.

Newer drugs in Cardiology: Colchicine, Ferric Carboxymaltose, Mavacamptan and beyond

In this enlightening discussion, we delve into the pivotal role of Novel Oral Anticoagulants (NOACs) in mitigating the risk of stroke in non-valvular atrial fibrillation (AF) patients. Gain comprehensive insights into the latest advancements, clinical efficacy, and safety profiles of NOACs compared to traditional anticoagulation therapies. Join us LIVE as we explore the evolving landscape of stroke prevention in AF, empowering you with the knowledge to make informed decisions for your patients' cardiovascular health.

Role of NOACs in non-valvular AF related stroke

Step into the captivating world of cardiology with us in the upcoming Pfizer Wizards of Medicine Cardiology Quiz Extravaganza! Prepare to embark on an exciting journey into the realm of heart health, where our esteemed panel of cardiology experts, Quizmaster Dr. Kamal Sharma & guest expert Dr. C.K Ponde, will unravel the mysteries behind cardiovascular disorders. Whether you're a medical enthusiast, a seasoned professional eager to expand your knowledge, or simply intrigued by the wonders of cardiology, this quiz promises an unforgettable journey. Test your knowledge in real-time with this thrilling adventure through the fascinating landscapes of cardiology ! 

Pfizer Wizards of Medicine - Cardiology

We are thrilled to announce the third episode of "Changing Practice: Monthly Roundup!" Join us as we delve into the most recent medical breakthroughs published in the month of May. Leading the discussion is our esteemed host, Dr. Mahadev Desai, joined by a panel of distinguished experts such as Dr. CK Ponde, Dr. Jay Shah & Dr. Shachi Joshi. In this episode, we discuss the latest on HPV vaccination, Iron deficiency in heart failure, Sodium intake guidelines for patients with heart failure & compare low-molecular-weight heparin and aspirin for thromboprophylaxis. 
Don't forget to share this #MustAttendSession with your colleagues and friends, and tune in to Medflix for a blockbuster discussion and stay up-to-date on the latest medical advancements!

Changing Practice: May Roundup!

Senior Consultant - Cardiologist & Head - Department of Non-Invasive Cardiology | P.D Hinduja Hospital, Mumbai

This session explores the evolving paradigm of cardio-renal-metabolic care, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations can improve outcomes in patients with type 2 diabetes and associated co-morbidities. It focuses on mechanisms, patient selection, real-world evidence, and practical strategies to achieve comprehensive heart, kidney, and metabolic protection in routine clinical practice.

Dr. Chandrashekhar K Ponde

11

4.6k

146.9k

4.8

Upcoming Sessions

Sessions Taken

728

4.6

206

4.7

430

4.7

603

5

802

5

1.7k

4.8

1.1k

4.8